NASDAQ: SAVA - Cassava Sciences, Inc.

Yield per half year: +34.17%
Sector: Healthcare

Share chart Cassava Sciences, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About

Cassava Sciences, Inc., биотехнологическая компания, работающая на клинической стадии, разрабатывает лекарства от расстройств нервной системы. Ведущим кандидатом в терапевтический продукт является низкомолекулярный препарат PTI-125, клинические испытания которого завершены в фазе 2b; Кандидат в исследуемый диагностический продукт - это SavaDx, биомаркер крови для диагностики болезни Альцгеймера. Компания ранее называлась Pain Therapeutics, Inc. и сменила название на Cassava Sciences, Inc. в марте 2019 года. Cassava Sciences, Inc.

More details
была основана в 1998 году и базируется в Остине, штат Техас.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

P/BV 7.6
EV/EBITDA -29.59
EBITDA -0.0049
Цена ао 28.43
Сайт https://www.cassavasciences.com
Число акций ао 0.04193 млрд
Див.доход ао 0
ISIN US14817C1071
Выручка 0
P/S -640328.52
Дивиденд ао 5.25
Валюта usd
IPO date 2000-07-14
Sector Health Care
Industry Pharmaceuticals
Валюта отчета usd
Change price per day: +10.19% (25.8)
Change price per week: +13.72% (25)
Change price per month: +0.3176% (28.34)
Change price per 3 month: +197.07% (9.57)
Change price per half year: +34.17% (21.19)
Change price per year: +98.67% (14.31)
Change price per 3 year: -34.3% (43.27)
Change price per 5 year: +244.61% (8.25)
Change price per year to date: +29.82% (21.9)
All parameters

Underestimation

Title Value Grade
P/S -707555.2 0
P/BV 7.3 1
P/E 0 0
EV/EBITDA -8.45 0
Total: 2.25

Efficiency

Title Value Grade
ROA, % -64.1 0
ROE, % -70.72 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0.5 5
Total: 0.7143

Debt

Title Value Grade
Debt/EBITDA -0.0013 10
Total: 9.6

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 1988.54 10
Yield EPS, % 850.96 10
Total: 8
More

Transaction date Date of disclosure Insider Type Price Volume Quantity Share before, % Share after, % Document
29.03.2022 29.03.2022 GUSSIN ROBERT Z
Director		 Purchase 21.53 160 829 7470 0 0.02 link

Institutions Volume Share, %
Blackrock Inc. 3037415 7.02
Vanguard Group Inc 2324626 5.38
State Street Corporation 1069649 2.47
Geode Capital Management, LLC 873996 2.02
Gallacher Capital Management LLC 581606 1.34
Morgan Stanley 541273 1.25
COWEN AND COMPANY, LLC 500000 1.16
Northern Trust Corporation 387666 0.9
JANE STREET GROUP, LLC 374206 0.87
Charles Schwab Investment Management, Inc. 308836 0.71

ETF Share, % Profitability for 1 year, % Dividends, %
Virtus LifeSci Biotech Clinical Trials ETF 1.1858 63.040315712071 0.33
JPMorgan BetaBuilders U.S. Small Cap Equity Fund 0.07838 24.74842126706 1.59225
Vanguard ESG U.S. Stock ETF 0 32.395678092399 1.26927
iShares ESG Aware MSCI USA Small-Cap ETF 0.04799 33.616398243045 1.49366
Fidelity MSCI Health Care Index ETF 0.01949 13.390080209527 1.46057
ProShares Hedge Replication ETF 0.0075 5.9237999659878 1.47892
Humankind US Stock ETF 0.00462 18.809430395549 1.99919
iShares Neuroscience and Healthcare ETF 2.35377 19.720292847757 0.03
iShares U.S. Pharmaceuticals ETF 0.51917 17.60673599431 1.97922
iShares Morningstar Small-Cap ETF 0.02898 30.095066471445 1.60498
iShares Morningstar Small-Cap Growth ETF 0.03395 33.628071953382 0.72598
iShares Morningstar Small Cap Value ETF 0.02411 26.701717953559 2.50476
iShares Russell 2000 Growth ETF 0.08992 38.042556988 0.6026
iShares Russell 3000 ETF 0.00201 32.57283798366 1.43482
iShares Morningstar Small-Cap ETF 0.02898 391.25300933451 1.60498
iShares Morningstar Small-Cap Growth ETF 0.03395 680.05582339508 0.72598
iShares Morningstar Small-Cap Value ETF 0.02411 227.12514109528 2.50476
Nuveen ESG Small-Cap ETF 0.14128 29.971671388102 1.41019
Direxion Daily Pharmaceutical & Medical Bull 3X Shares 2.13161 86.715867158672 1.2989
Schwab U.S. Small-Cap ETF 0.03411 34.281650071124 1.51433
Schwab U.S. Broad Market ETF 0.00204 32.5 1.43354
SPDR Portfolio MSCI Global Stock Market ETF 0.00114 23.600605143722 2.19607
FlexShares Morningstar US Market Factor Tilt Index Fund 0.00343 32.205226109465 1.69572
ProShares UltraPro Russell2000 0.02613 89.821266282945 1.47873
Vanguard Russell 3000 ETF 0 31.87314172448 1.43817
Vanguard Russell 2000 Growth ETF 0.09 39.350070246167 0.60264
Vanguard Russell 2000 ETF 0.04 35.648084105685 1.48801
SPDR S&P Pharmaceuticals ETF 3.0256 29.798803697662 1.29889



Head Job title Payment Year of birth
Mr. Eric J. Schoen Chief Financial Officer 460k 1968 (56 years)
Mr. Michael Zamloot Senior Vice President of Technical Operations N/A
Dr. Lindsay H. Burns Ph.D. Senior Vice President of Neuroscience N/A
Dr. James W. Kupiec M.D. Chief Medical Officer 435k 1953 (71 year)
Mr. R. Christopher Cook Senior VP, Company Secretary & General Counsel 425k 1964 (60 years)
Dr. Michael Marsman Pharm.D. Senior Vice President of Regulatory Affairs N/A
Dr. George Thornton Ph.D. Senior Vice President of Technology N/A
Mr. Richard Jon Barry CEO & Director 1959 (65 years)

Address: United States, Austin, TX , 7801 North Capital of Texas Highway - open in Google maps, open in Yandex maps
Website: https://www.cassavasciences.com